» Articles » PMID: 37836529

Cancer Metabolism As a Therapeutic Target and Review of Interventions

Overview
Journal Nutrients
Date 2023 Oct 14
PMID 37836529
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is amenable to low-cost treatments, given that it has a significant metabolic component, which can be affected through diet and lifestyle change at minimal cost. The Warburg hypothesis states that cancer cells have an altered cell metabolism towards anaerobic glycolysis. Given this metabolic reprogramming in cancer cells, it is possible to target cancers metabolically by depriving them of glucose. In addition to dietary and lifestyle modifications which work on tumors metabolically, there are a panoply of nutritional supplements and repurposed drugs associated with cancer prevention and better treatment outcomes. These interventions and their evidentiary basis are covered in the latter half of this review to guide future cancer treatment.

Citing Articles

Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.

Zhang Y, Lun H, Zhu N, Yang N, Ding K, Chen B Front Oncol. 2025; 14():1485605.

PMID: 39850812 PMC: 11754200. DOI: 10.3389/fonc.2024.1485605.


RNA modifications in cancer.

Wu H, Chen S, Li X, Li Y, Shi H, Qing Y MedComm (2020). 2025; 6(1):e70042.

PMID: 39802639 PMC: 11718328. DOI: 10.1002/mco2.70042.


DNMT1-driven methylation of RORA facilitates esophageal squamous cell carcinoma progression under hypoxia through SLC2A3.

Yao W, Shang L, Wang Y, Xu L, Bai Y, Feng M J Transl Med. 2024; 22(1):1167.

PMID: 39741267 PMC: 11686977. DOI: 10.1186/s12967-024-05960-8.


Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches.

Li Z, Li N, Ndzie Noah M, Shao Q, Zhan X EPMA J. 2024; 15(4):711-737.

PMID: 39635022 PMC: 11612093. DOI: 10.1007/s13167-024-00385-1.


NF-κB signaling pathway in tumor microenvironment.

Cao Y, Yi Y, Han C, Shi B Front Immunol. 2024; 15:1476030.

PMID: 39493763 PMC: 11530992. DOI: 10.3389/fimmu.2024.1476030.


References
1.
Li X, Liu C, Dong S, Ou C, Lu J, Ye J . Anticarcinogenic potentials of tea catechins. Front Nutr. 2022; 9:1060783. PMC: 9760998. DOI: 10.3389/fnut.2022.1060783. View

2.
Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M . Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020; 20(1):791. PMC: 7446227. DOI: 10.1186/s12885-020-07256-8. View

3.
CHAPUY M, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S . Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997; 7(5):439-43. DOI: 10.1007/s001980050030. View

4.
Wang Q, Zhou W . Roles and molecular mechanisms of physical exercise in cancer prevention and treatment. J Sport Health Sci. 2020; 10(2):201-210. PMC: 7987556. DOI: 10.1016/j.jshs.2020.07.008. View

5.
Zhang P, Li H, Tan X, Chen L, Wang S . Association of metformin use with cancer incidence and mortality: a meta-analysis. Cancer Epidemiol. 2013; 37(3):207-18. DOI: 10.1016/j.canep.2012.12.009. View